$10.13
-0.88-7.99%
At Close: -
$10.93
0.87.91%
After Hours: Jul 19, 9:18 AM EDT
15 minutes delayed
Atara Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Atara Biotherapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ATRA | Atara Biotherapeutics | -$17.00 | -$1.56 | — | — | $957.00K | $39.99M | — | — | 08/06/2024 | Get Alert |
ATRA | Atara Biotherapeutics | -$18.00 | -$6.50 | -$5.75 | 11.54% | $1.23M | $24.69M | $27.36M | 10.80% | 05/09/2024 | Get Alert |
ATRA | Atara Biotherapeutics | -$18.00 | -$12.00 | -$14.00 | -16.67% | $221.00K | $11.55M | $4.25M | -63.19% | 03/28/2024 | Get Alert |
ATRA | Atara Biotherapeutics | -$20.50 | -$16.50 | -$16.50 | 0.00% | $4.46M | $4.76M | $2.14M | -55.08% | 11/01/2023 | Get Alert |
ATRA | Atara Biotherapeutics | -$7.75 | -$16.75 | -$17.00 | -1.49% | $51.58M | $3.77M | $957.00K | -74.62% | 08/08/2023 | Get Alert |
ATRA | Atara Biotherapeutics | -$21.75 | -$9.75 | -$18.00 | -84.62% | $7.31M | $30.68M | $1.23M | -96.00% | 05/08/2023 | Get Alert |
ATRA | Atara Biotherapeutics | -$24.00 | -$12.75 | -$18.00 | -41.18% | $7.55M | $39.67M | $221.00K | -99.44% | 02/08/2023 | Get Alert |
ATRA | Atara Biotherapeutics | -$22.50 | -$19.50 | -$20.50 | -5.13% | $5.37M | $5.27M | $4.46M | -15.39% | 11/08/2022 | Get Alert |
ATRA | Atara Biotherapeutics | -$22.75 | -$23.25 | -$7.75 | 66.67% | $3.87M | $6.84M | $51.58M | 654.08% | 08/08/2022 | Get Alert |
ATRA | Atara Biotherapeutics | -$21.50 | -$24.50 | -$21.75 | 11.22% | $3.55M | $4.91M | $7.31M | 48.96% | 05/05/2022 | Get Alert |
ATRA | Atara Biotherapeutics | -$23.75 | -$17.25 | -$24.00 | -39.13% | $0.00 | $35.14M | $7.55M | -78.52% | 02/28/2022 | Get Alert |
ATRA | Atara Biotherapeutics | -$23.00 | -$23.50 | -$22.50 | 4.26% | $0.00 | $3.92M | $5.37M | 36.99% | 11/04/2021 | Get Alert |
ATRA | Atara Biotherapeutics | -$28.50 | -$22.25 | -$22.75 | -2.25% | $0.00 | $3.84M | $3.87M | 0.78% | 08/09/2021 | Get Alert |
ATRA | Atara Biotherapeutics | -$30.00 | -$23.00 | -$21.50 | 6.52% | $0.00 | $1.60M | $3.55M | 122.00% | 05/04/2021 | Get Alert |
ATRA | Atara Biotherapeutics | -$34.00 | -$18.50 | -$23.75 | -28.38% | $0.00 | $13.33M | $0.00 | -100.00% | 03/01/2021 | Get Alert |
ATRA | Atara Biotherapeutics | -$32.75 | -$27.25 | -$23.00 | 15.60% | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
ATRA | Atara Biotherapeutics | -$40.00 | -$29.50 | -$28.50 | 3.39% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
ATRA | Atara Biotherapeutics | -$36.00 | -$35.25 | -$30.00 | 14.89% | $0.00 | — | $0.00 | — | 05/06/2020 | Get Alert |
ATRA | Atara Biotherapeutics | -$43.75 | -$33.50 | -$34.00 | -1.49% | $0.00 | — | $0.00 | — | 02/27/2020 | Get Alert |
ATRA | Atara Biotherapeutics | -$32.25 | -$36.00 | -$32.75 | 9.03% | $0.00 | — | $0.00 | — | 11/07/2019 | Get Alert |
ATRA | Atara Biotherapeutics | -$28.75 | -$37.50 | -$40.00 | -6.67% | $0.00 | — | $0.00 | — | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-5.75 | $-6.50 | 11.5 % |
Dec 2023 | 2024-03-28 | $-14.00 | $-12.00 | -16.7 % |
Sep 2023 | 2023-11-01 | $-16.50 | $-16.50 | 0.00 % |
Jun 2023 | 2023-08-08 | $-17.00 | $-16.75 | -1.49 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $27.36M | $24.69M | 10.8 % |
Dec 2023 | 2024-03-28 | $4.25M | $11.55M | -63.2 % |
Sep 2023 | 2023-11-01 | $2.14M | $4.76M | -55.1 % |
Jun 2023 | 2023-08-08 | $957.00K | $3.77M | -74.6 % |
Atara Biotherapeutics (ATRA) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-5.75, which beat the estimate of $-6.50.
The Actual Revenue was $27.4M, which beat the estimate of $24.7M.
Browse earnings estimates, EPS, and revenue on all stocks.